Investors Win Class Cert. Against Failed COVID Test Maker

By Emilie Ruscoe · February 12, 2024, 10:16 PM EST

Investors suing biotech company Talis Biomedical Corp. have received class certification in a suit alleging the company hurt investors when trading prices sank a month after its initial public offering when...

To view the full article, register now.

Documents

Case Information

Case Title

IN RE Talis Biomedical Securities Litigation

Case Number

3:22-cv-00105

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 07, 2022